This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gómez-Martínez, A. Articles by Saceda, M. Search for Related Content PubMed PubMed Citation Articles by Gómez-Martínez, A. Articles by Saceda, M.

---

Signaling and Regulation

Post-transcriptional Regulation of P-Glycoprotein Expression in Cancer Cell Lines

¹ Instituto de Biología Molecular y Celular, Universidad Miguel Hernández and ² Hospital Universitario Elche 03203 Elche (Alicante), Spain

Requests for reprints: Miguel Saceda, Instituto de Biología Molecular y Celular, Ed. Torregaitan, Universidad Miguel Hernández, 03202 Elche (Alicante), Spain. Phone: 34-96-6658432; Fax: 34-96-6658758. E-mail: msaceda{at}umh.es

The present study of inhibitors shows that the histone deacetylase–induced increase in P-glycoprotein (Pgp) mRNA (MDR1 mRNA) does not parallel either an increase in Pgp protein or an increase in Pgp activity in several colon carcinoma cell lines. Furthermore, studying the polysome profile distribution, we show a translational control of Pgp in these cell lines. In addition, we show that the MDR1 mRNA produced in these cell lines is shorter in its 5' end that the MDR1 mRNA produced in the MCF-7/Adr (human breast carcinoma) and K562/Adr (human erythroleukemia) cell lines, both of them expressing Pgp. The different size of the MDR1 mRNA is due to the use of alternative promoters. Our data suggest that the translational blockade of MDR1 mRNA in the colon carcinoma cell lines and in wild-type K562 cells could be overcome by alterations in the 5' end of the MDR1 mRNA in the resistant variant of these cell lines, as in the case of the K562/Adr cell line. This is, to our knowledge, the first report demonstrating that the presence of an additional 5' untranslated fragment in the MDR1 mRNA improves the translational efficiency of this mRNA. (Mol Cancer Res 2007;5(6):641–53)

This article has been cited by other articles:

				R. Callaghan, E. Crowley, S. Potter, and I. D. Kerr P-glycoprotein: So Many Ways to Turn It On J. Clin. Pharmacol., March 1, 2008; 48(3): 365 - 378. [Abstract] [Full Text] [PDF]